No one is immune to the effects of the world’s most pressing medical challenges. And none of these challenges are immune to the brilliance and dedication of IMRIC’s researchers. Get to know them a little better by checking out their bios.

A (3) | B (4) | C (2) | D (2) | F (1) | G (1) | H (1) | I (1) | J (1) | K (6) | L (3) | M (2) | O (1) | P (3) | R (2) | S (3) | W (1) | Y (3)

Dr. Aharon Lev-Tov

Based on my initial academic studies, nobody could guess that I would be doing research for IMRIC in neurobiology and spinal cord injuries. My first degree was in Agriculture, which is what the kibbutz wanted me to do. But my initial research into taste receptors of the honey bee got me interested in neurobiology. So even though I completed my studies, I requested and received permission from them [the kibbutz] to pursue a degree in neurobiology.

Spinal cord injury interested me before I became an IMRIC researcher, but in the last few years, my IMRIC team has been able to translate our findings to human studies with significant positive results. Now we are working in collaboration with the University of British Columbia in Vancouver, the University of Calgary and the Rick Hansen Institute, to improve our understanding of spinal cord injuries and develop improved methods of treatment.

Prof. David Lichtstein

To me, becoming a scientist was the only means to satisfy my curiosity of the laws on nature.  As a child, I was curious about a lot of things, such as: where water goes when it is boiled, why cows eat grass and we don’t, why dogs don’t talk, and so on.  Of course, as anyone with an interest in science and without sufficient knowledge, I tried “experiments" with mostly bizarre results.  But that did not stop me from being curious.

During my high school days, the field that excited me the most was biology and in particular the human body and the way it functions. I choose medical sciences as a career because of the combination it offers of being a scientist and at the same time being engaged in work that may influence the life of many people all over the world.

Prof. Haya Lorberboum-Galski

Prof. Haya LorberboumGalski was born in Lignitza, Poland, and immigrated to Israel as a baby. Following her army service (where she served as an officer), she received her Ph.D. in Biochemistry from the Hebrew University. She was a postdoctoral fellow at the Molecular Biology Laboratory, NCI, NIH.

Her research interests focus on developing reagents for targeted human therapy (chimeric/fusion proteins), cancer, metabolic diseases,immune responses and mechanisms of apoptosis. She has published over 60 publications in peerreviewed journals, as well as review articles, and edited a book on chimeric proteins. She currently heads the IMRIC research committee at the Faculty of Medicine. Haya is the proud mother of  two wonderful children, one of whom now is serving in the army.

"Since 1989, I have been part of the Hebrew University Faculty of Medicine, involved in my own research on developing reagents for targeted human therapy. But my biggest role is my work at IMRIC, where I help direct the operations of IMRIC and its dynamic team of researchers. Their individual work and their collaborations with other researchers in Canada are making a major contribution toward finding solutions to the major medical problems we face today. I am fortunate to be a part of that team."

Research focus: Development of specific immunosuppressive agents. Cancer: mechanisms and treatment. Immune responses - mechanisms and pathways.